Aigen Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-20,153
| Closed | -$1.68M | – | 1090 |
|
|
2024
Q4 | $1.68M | Buy |
20,153
+5,263
| +35% | +$440K | 0.3% | 86 |
|
|
2024
Q3 | $1.09M | Buy |
14,890
+7,105
| +91% | +$520K | 0.21% | 133 |
|
|
2024
Q2 | $533K | Buy |
+7,785
| New | +$533K | 0.1% | 288 |
|
|
2023
Q3 | – | Sell |
-14,220
| Closed | -$900K | – | 1126 |
|
|
2023
Q2 | $900K | Buy |
14,220
+5,810
| +69% | +$368K | 0.13% | 226 |
|
|
2023
Q1 | $455K | Buy |
+8,410
| New | +$455K | 0.06% | 331 |
|
|
2020
Q4 | – | Sell |
-64,625
| Closed | -$1.66M | – | 1142 |
|
|
2020
Q3 | $1.66M | Buy |
+64,625
| New | +$1.66M | 0.21% | 143 |
|
|
2020
Q1 | – | Sell |
-1,199
| Closed | -$41K | – | 1622 |
|
|
2019
Q4 | $41K | Buy |
+1,199
| New | +$41K | 0.01% | 839 |
|